[1] Kimura I, Ichimura A, Ohue-Kitano R, Igarashi M. Free fatty acid receptors in
health and disease. Physiological Reviews 2020;100(1):171e210.
[2] Canals M, Poole DP, Veldhuis NA, Schmidt BL, Bunnett NW. G-Protein-Coupled
receptors are dynamic regulators of digestion and targets for digestive diseases. Gastroenterology 2019;156(6):1600e16.
[3] Miyamoto J, Igarashi M, Watanabe K, Karaki SI, Mukouyama H, Kishino S,
et al. Gut microbiota confers host resistance to obesity by metabolizing dietary
polyunsaturated fatty acids. Nature Communications 2019;10(1):4007.
[4] Hosomi K, Kiyono H, Kunisawa J. Fatty acid metabolism in the host and
commensal bacteria for the control of intestinal immune responses and diseases. Gut Microbes 2020;11(3):276e84.
[5] Hansen HS, Rosenkilde MM, Holst JJ, Schwartz TW. GPR119 as a fat sensor.
Trends in Pharmacological Sciences 2012;33(7):374e81.
[6] Neunlist M, Schemann M. Nutrient-induced changes in the phenotype and
function of the enteric nervous system. Journal of Physiology 2014;592(14):
2959e65.
[7] Psichas A, Reimann F, Gribble FM. Gut chemosensing mechanisms. Journal of
Clinical Investigation 2015;125(3):908e17.
[8] Lan H, Vassileva G, Corona A, Liu L, Baker H, Golovko A, et al. GPR119 is
required for physiological regulation of glucagon-like peptide-1 secretion but
not for metabolic homeostasis. Journal of Endocrinology 2009;201(2):219e30.
[9] Panaro BL, Flock GB, Campbell JE, Beaudry JL, Cao X, Drucker DJ. Beta-Cell
inactivation of Gpr119 unmasks incretin dependence of GPR119-mediated
glucoregulation. Diabetes 2017;66(6):1626e35.
14
[10] Higuchi S, Ahmad TR, Argueta DA, Perez PA, Zhao C, Schwartz GJ, et al. Bile
acid composition regulates GPR119-dependent intestinal lipid sensing and
food intake regulation in mice. Gut 2020;69(9):1620e8.
[11] Piomelli D. A fatty gut feeling. Trends in Endocrinology and Metabolism
2013;24(7):332e41.
[12] Fu J, Astarita G, Gaetani S, Kim J, Cravatt BF, Mackie K, et al. Food intake
regulates oleoylethanolamide formation and degradation in the proximal small
intestine. Journal of Biological Chemistry 2007;282(2):1518e28.
[13] Schwartz GJ, Fu J, Astarita G, Li X, Gaetani S, Campolongo P, et al. The lipid
messenger OEA links dietary fat intake to satiety. Cell Metabolism 2008;8(4):
281e8.
[14] Fu J, Oveisi F, Gaetani S, Lin E, Piomelli D. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese
rats. Neuropharmacology 2005;48(8):1147e53.
[15] Lauffer LM, Iakoubov R, Brubaker PL. GPR119 is essential for
oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes 2009;58(5):1058e66.
[16] Chen Z, Guo L, Zhang Y, Walzem RL, Pendergast JS, Printz RL, et al. Incorporation of therapeutically modified bacteria into gut microbiota inhibits
obesity. Journal of Clinical Investigation 2014;124(8):3391e406.
[17] Dosoky NS, Guo L, Chen Z, Feigley AV, Davies SS. Dietary fatty acids control
the species of N-Acyl-Phosphatidylethanolamines synthesized by therapeutically modified bacteria in the intestinal tract. ACS Infectious Diseases
2018;4(1):3e13.
[18] Cohen LJ, Esterhazy D, Kim SH, Lemetre C, Aguilar RR, Gordon EA, et al.
Commensal bacteria make GPCR ligands that mimic human signalling molecules. Nature 2017;549(7670):48e53.
[19] Gaetani S, Oveisi F, Piomelli D. Modulation of meal pattern in the rat by the
anorexic lipid mediator oleoylethanolamide. Neuropsychopharmacology
2003;28(7):1311e6.
[20] Igarashi M, Watanabe K, Tsuduki T, Kimura I, Kubota N. NAPE-PLD controls
OEA synthesis and fat absorption by regulating lipoprotein synthesis in an
in vitro model of intestinal epithelial cells. The FASEB Journal 2019;33(3):
3167e79.
[21] Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, et al. The gut
microbiota suppresses insulin-mediated fat accumulation via the short-chain
fatty acid receptor GPR43. Nature Communications 2013;4:1829.
[22] Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, et al. Free
fatty acids regulate gut incretin glucagon-like peptide-1 secretion through
GPR120. Nature Medicine 2005;11(1):90e4.
[23] Svendsen B, Pedersen J, Albrechtsen NJ, Hartmann B, Torang S, Rehfeld JF,
et al. An analysis of cosecretion and coexpression of gut hormones from male
rat proximal and distal small intestine. Endocrinology 2015;156(3):847e57.
[24] Bowen KJ, Kris-Etherton PM, Shearer GC, West SG, Reddivari L, Jones PJH.
Oleic acid-derived oleoylethanolamide: a nutritional science perspective.
Progress in Lipid Research 2017;67:1e15.
[25] Rodriguez de Fonseca F, Navarro M, Gomez R, Escuredo L, Nava F, Fu J, et al.
An anorexic lipid mediator regulated by feeding. Nature 2001;414(6860):209e
12.
[26] Oveisi F, Gaetani S, Eng KT, Piomelli D. Oleoylethanolamide inhibits food intake
in free-feeding rats after oral administration. Pharmacological Research
2004;49(5):461e6.
[27] Lo Verme J, Gaetani S, Fu J, Oveisi F, Burton K, Piomelli D. Regulation of food
intake by oleoylethanolamide. Cellular and Molecular Life Sciences
2005;62(6):708e16.
[28] Moss CE, Glass LL, Diakogiannaki E, Pais R, Lenaghan C, Smith DM, et al.
Lipid derivatives activate GPR119 and trigger GLP-1 secretion in primary
murine L-cells. Peptides 2016;77:16e20.
[29] Steinert RE, Beglinger C, Langhans W. Intestinal GLP-1 and satiation: from
man to rodents and back. International Journal of Obesity 2016;40(2):198e
205.
MOLECULAR METABOLISM 67 (2023) 101649 Ó 2022 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
www.molecularmetabolism.com
[30] Krieger JP. Intestinal glucagon-like peptide-1 effects on food intake:
physiological relevance and emerging mechanisms. Peptides 2020;131:
170342.
[31] Panaro BL, Yusta B, Matthews D, Koehler JA, Song Y, Sandoval DA, et al.
Intestine-selective reduction of Gcg expression reveals the importance of the
distal gut for GLP-1 secretion. Molecular Metabolism 2020;37:100990.
[32] Lou PH, Gustavsson N, Wang Y, Radda GK, Han W. Increased lipolysis and
energy expenditure in a mouse model with severely impaired glucagon
secretion. PLoS One 2011;6(10):e26671.
[33] Li NX, Brown S, Kowalski T, Wu M, Yang L, Dai G, et al. GPR119 agonism
increases glucagon secretion during insulin-induced hypoglycemia. Diabetes
2018;67(7):1401e13.
[34] Suárez J, Rivera P, Arrabal S, Crespillo A, Serrano A, Baixeras E, et al.
Oleoylethanolamide enhances b-adrenergic-mediated thermogenesis and
white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat.
Dis Model Mech 2014;7(1):129e41.
[35] Miller S, Hu SS, Leishman E, Morgan D, Wager-Miller J, Mackie K, et al.
A GPR119 signaling system in the murine eye regulates intraocular pressure in
a sex-dependent manner. Investigative Ophthalmology & Visual Science
2017;58(7):2930e8.
[36] Odori S, Hosoda K, Tomita T, Fujikura J, Kusakabe T, Kawaguchi Y, et al.
GPR119 expression in normal human tissues and islet cell tumors: evidence
for its islet-gastrointestinal distribution, expression in pancreatic beta and
alpha cells, and involvement in islet function. Metabolism 2013;62(1):70e8.
MOLECULAR METABOLISM 67 (2023) 101649 Ó 2022 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
www.molecularmetabolism.com
15
...
論文の公開元へ
